Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
High Sierra Technologies's 3-Year RORE % for the quarter that ended in Sep. 2025 was -4.50%.
The industry rank for High Sierra Technologies's 3-Year RORE % or its related term are showing as below:
HSTI's 3-Year RORE % is not ranked
in the Drug Manufacturers industry.
Industry Median: 3.09
vs HSTI: -4.50
High Sierra Technologies (OTCPK:HSTI) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
High Sierra Technologies 3-Year RORE % Related Terms
High Sierra Technologies 3-Year RORE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HSTI vs HYEX, APUS, INIS: 3-Year RORE % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, High Sierra Technologies's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
High Sierra Technologies 3-Year RORE % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, High Sierra Technologies's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where High Sierra Technologies's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Sep. 2025 and 3-year before.
High Sierra Technologies (HSTI) has a 3-Year RORE % of -4.50 as of Sep. 2025. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on High Sierra Technologies and its competitors.
Is High Sierra Technologies' 3-Year RORE % too high?
High Sierra Technologies' current 3-Year RORE % is -4.50. Overall, High Sierra Technologies has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does High Sierra Technologies' 3-Year RORE % compare to HYEX and APUS?
High Sierra Technologies' 3-Year RORE % of -4.50 can be compared against companies in the Drug Manufacturers industry. The industry median 3-Year RORE % is 3.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Drug Manufacturers company?
The median 3-Year RORE % among Drug Manufacturers companies is 3.09, based on 937 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on High Sierra Technologies and its competitors. For the Drug Manufacturers industry, the median 3-Year RORE % is 3.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. High Sierra Technologies's current 3-Year RORE % is -4.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is High Sierra Technologies stock overvalued right now?
High Sierra Technologies (HSTI) has a current 3-Year RORE % of -4.50. The current 3-Year RORE % is -4.50. High Sierra Technologies' overall GF Score™ is 18/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For High Sierra Technologies (HSTI), the current 3-Year RORE % is -4.50 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
High Sierra Technologies Inc is a start-up that develops and expands its intellectual property portfolio with an emphasis on the recreational cannabis industry as well as the industrial hemp industry. The company owns two provisional patent applications for producing new and novel cannabis products including low odor cannabis for smoking or as the starting materials for producing low odor cannabis products or flavored cannabis products.
18GF Score
Get the complete analysis for HSTI
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSTI has been successfully added to your 
